Immunomodulatory Effects of Pevonedistat, a NEDD8-Activating Enzyme (NAE) Inhibitor, in Chronic Lymphocytic Leukemia (CLL)

被引：0
|
作者：
Best, Scott R. [1 ]
Kittai, Adam [2 ]
Rowland, Taylor [1 ]
Bruss, Nur [1 ]
Spurgeon, Stephen E. [2 ]
Berger, Allison [3 ]
Moran, Amy [1 ]
Danilov, Alexey V. [2 ]
机构：
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[2] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA
[3] Takeda Pharmaceut Int Co, Oncol Drug Discovery Unit, Cambridge, MA USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-115086
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2946
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Immunomodulatory effects of pevonedistat, a NEDD8-activating enzyme inhibitor, in chronic lymphocytic leukemia-derived T cells
    Scott Best
    Vi Lam
    Tingting Liu
    Nur Bruss
    Adam Kittai
    Olga V. Danilova
    Susan Murray
    Allison Berger
    Nathan D. Pennock
    Evan F. Lind
    Alexey V. Danilov
    Leukemia, 2021, 35 : 156 - 168
  • [2] Immunomodulatory effects of pevonedistat, a NEDD8-activating enzyme inhibitor, in chronic lymphocytic leukemia-derived T cells
    Best, Scott
    Lam, Vi
    Liu, Tingting
    Bruss, Nur
    Kittai, Adam
    Danilova, Olga V.
    Murray, Susan
    Berger, Allison
    Pennock, Nathan D.
    Lind, Evan F.
    Danilov, Alexey V.
    LEUKEMIA, 2021, 35 (01) : 156 - 168
  • [3] Synthesis of two isotopically labeled versions of NEDD8-activating enzyme (NAE) inhibitor
    Li, Yuexian
    Plesescu, Mihaela
    Prakash, Shimoga R.
    TETRAHEDRON LETTERS, 2011, 52 (15) : 1807 - 1810
  • [4] Oncolytic virus and inhibitor for NEDD8-activating enzyme pevonedistat: Promising combination for cancer therapy?
    Guo, Zong Sheng
    MOLECULAR THERAPY, 2023, 31 (11) : 3112 - 3114
  • [5] PEVONEDISTAT, A FIRST-IN-CLASS NEDD8-ACTIVATING ENZYME INHIBITOR, IS A POTENT INHIBITOR OF HEPATITIS B VIRUS
    Sekiba, Kazuma
    Otsuka, Motoyuki
    Koike, Kazuhiko
    GASTROENTEROLOGY, 2019, 156 (06) : S1194 - S1194
  • [6] Therapeutic Effects of a NEDD8-Activating Enzyme Inhibitor, Pevonedistat, on Sclerodermatous Graft-versus-Host Disease in Mice
    Pai, Chien-Chun Steven
    Khuat, Lam T.
    Chen, Mingyi
    Murphy, William J.
    Abedi, Mehrdad
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (01) : 30 - 37
  • [7] Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AML
    Swords, Ronan T.
    Coutre, Steven
    Maris, Michael B.
    Zeidner, Joshua F.
    Foran, James M.
    Cruz, Jose
    Erba, Harry P.
    Berdeja, Jesus G.
    Tam, Wayne
    Vardhanabhuti, Saran
    Pawlikowska-Dobler, Iwona
    Faessel, Helene M.
    Dash, Ajeeta B.
    Sedarati, Farhad
    Dezube, Bruce J.
    Faller, Douglas V.
    Savona, Michael R.
    BLOOD, 2018, 131 (13) : 1415 - 1424
  • [8] Asymmetric Synthesis of Fluoro-MLN4924 as a Selective NEDD8-Activating Enzyme (NAE) Inhibitor
    Kim, Hong-Rae
    Jarhad, Dnyandev B.
    Sahu, Pramod K.
    Sung, Kisu
    An, Dayoung
    Hyun, Young Eum
    Yu, Jinha
    Jeong, Lak Shin
    ASIAN JOURNAL OF ORGANIC CHEMISTRY, 2019, 8 (09) : 1641 - 1647
  • [9] Targeting the protein ubiquitination machinery in melanoma by the NEDD8-activating enzyme inhibitor pevonedistat (MLN4924)
    Wong, Kit Man
    Micel, Lindsey N.
    Selby, Heather M.
    Tan, Aik Choon
    Pitts, Todd M.
    Bagby, Stacey M.
    Spreafico, Anna
    Klauck, Peter J.
    Blakemore, Stephen J.
    Smith, Peter F.
    McDonald, Alice
    Berger, Allison
    Tentler, John J.
    Eckhardt, S. Gail
    INVESTIGATIONAL NEW DRUGS, 2017, 35 (01) : 11 - 25
  • [10] Pevonedistat, a NEDD8-activating enzyme inhibitor, is active in mantle cell lymphoma and enhances rituximab activity in vivo
    Czuczman, Natalie M.
    Barth, Matthew J.
    Gu, Juan
    Neppalli, Vishala
    Mavis, Cory
    Frys, Sarah E.
    Hu, Qiang
    Liu, Song
    Klener, Pavel
    Vockova, Petra
    Czuczman, Myron S.
    Hernandez-Ilizaliturri, Francisco J.
    BLOOD, 2016, 127 (09) : 1128 - 1137
12345